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Summary
The contribution of the mitochondrial components, the main source of energy for the cardiac hypertrophic
growth induced by pressure overload, is not well understood. In the present study, complete coarctation of
abdominal aorta was used to induce the rapid development of cardiac hypertrophy in rats. One to two days
after surgery, we observed signiﬁcantly higher blood pressure and cardiac hypertrophy, which remained
constantly high afterwards. We found an early increased level of cytochrome c oxidase (COX) mRNA
determined by in-situ hybridization and dot blotting assays in the hypertrophied hearts, and a drop to the
baseline 20 days after surgery. Similarly, mitochondrial COX protein level and enzyme activity increased
and, however, dropped even lower than baseline 20 days following surgery. In addition, in natural
hypertension-induced hypertrophic hearts in genetically hypertensive rats, the COX protein was signiﬁ-
cantly lower than in normotensive rats. Taken together, the lower eﬃciency of mitochondrial activity in the
enlarged hearts of long-term complete coarcted rats or genetically hypertensive rats could be, at least
partially, the cause of hypertensive cardiac disease. Additionally, the rapid complete coarctation-induced
cardiac hypertrophy was accompanied by a disproportionate COX activity increase, which was suggested
to maintain the cardiac energy-producing capacity in overloaded hearts.
Introduction
The heart has a remarkable capacity to increase its
mass in response to an increased work load, such as
pressure overload, induced either pathologically or
experimentally [1]. In order to be able to face the
increase of cardiac muscle contraction for extra
work, more energy production is required. The
mitochondrial compartment is the main source of
energy needed for hypertrophic growth in the myo-
cyte. However, the reports evaluating the mito-
chondrial compartment behavior during the onset
and progression of cardiac hypertrophy are incon-
sistent [2]. In addition, the investigations on the
molecular events involved in mitochondrial biogen-
esis and function during the hypertrophy process
are few. This is surprising since it is well-known that
*To whom correspondence should be addressed. phone +886-
4-24730022 ext. 11682; E-mail: chuang1@csmu.edu.tw
Journal of Biomedical Science (2005) 12:601–610 601
DOI 10.1007/s11373-005-7373-2
insuﬃcient oxidative capacity often contributes to
the cardiac failure observed at least in late stage
hypertrophic cardiomyopathies [3,4].
Cytochrome c oxidase (COX) is located in the
inner membrane of mitochondria and is the last
component of respiration chain. This enzyme
catalyzes the rate-limiting reaction of the mito-
chondrial oxidative phosphorylation (OXPHOS),
which supplies the energy for cardiac contraction
[5, 6]. Therefore, COX plays an essential role in
maintaining normal cardiac function. Since the
eﬀects of this enzyme are important, the reaction
rate of the mitochondrial OXPHOS can be altered
by a small decrease in this oxidase activity under
physiological condition. This tight control of COX
suggests that the dysfunction of the enzyme may
cause the mitochondrial myopathy [7, 8]. Actually,
the number of known mutations of most of the
genes encoding the protein subunits of COX in
patients with cardiomyopathy has increased [9–11].
Aortic constriction has been used to induce
cardiac hypertrophy in many studies. Our previous
data showed that the heart was rapidly enlarged
within 1–2 days postsurgery in thismodel by using a
complete coarctation of the abdominal aorta in rats
to induce a cardiac pressure overload [2,12,13]. In
the present study, we investigated the biochemical
and molecular events underlying the adaptation of
the mitochondrial compartment to meet the in-
creased energy demands of the cardiomyocyte as
they underwent this rapid hypertrophic growth.We
have used COX as a model protein for investigating
the underlying adaptive mechanism. We measured
COX activity and examined COX gene expression
by determining COX-Vb mRNA, one of the
nuclear-encoded subunits of COX enzyme, during
cardiac hypertrophy in the model system using
complete coarctation of the abdominal aorta from 1
to 20 days. The measurement of cardiac COX
protein in spontaneously hypertensive rats (SHR)
and stroke prone SHR (SPSHR) with naturally
occurring hypertensive cardiac hypertrophy was
also included in this study.
Methods
Coarctation of abdominal aorta
Male Sprague-Dawley rats weighing between 240
and 300 g were used to induce cardiac hypertrophy
by complete coarctation of the abdominal aorta
between the origins of the renal arteries [14]. After
a rat was anesthetized with pentobarbital sodium
(45.5 mg/kg), its left side was shaved and a
horizontal incision 3 cm in length was made.
Using curved hemostats, the superﬁcial fascia were
separated and an incision of the same size was
made into the abdominal musculature. The viscera
were exposed, and adipose tissue was separated
from the left kidney which was moved to obtain
maximal clearance to the abdominal aorta. The
abdominal aorta was isolated and completely
coarcted with a ligature (Coats, Dual Duty Plus,
carpet thread) ﬁxed between the origins of the
renal arteries. The left kidney and adipose tissue
were returned to their normal positions, the
abdominal musculature was rejoined using coated
vicryl sutures (Ethicon, Johnson & Johnson, FS-2
cutting), and the epidermis was rejoined using
wound clips. Then, a solution of l% iodine in 70%
ethanol was used to clean the wound. The rats
were returned to the animal care room (one per
cage) and allowed to recover. All animals were fed
standard rat chow and water supplemented with
tetracycline (22 mg/kg body weight) to ward oﬀ
infection. Sham rats were subjected to the same
procedure, but no ligature was placed. All animals
were handled according to the guidelines of the
Taiwan Society for Laboratory Animal Sciences
for the Care and Use of Laboratory Animals.
Femoral arterial pressure measurement
The blood pressure of coarcted and sham animals
was measured at l, 2, 3, 5, 7, 10 and 20 days
postsurgery. The animals not subjected to the above
surgery were measured as 0 day controls. After
catheterization of the femoral artery of animals,
blood pressuremonitor (Recorder 2200S,GOULD,
U.S.A.) was used to measure both the systolic and
diastolic pressure by connecting the femoral artery
with a sensor. The bloodpressurewasmeasured and
recorded continuously [15].
Heart isolation
Once the blood pressure measurements were taken,
the animals were sacriﬁced by cervical transaction.
The thoracic cavity was opened, and the heart was
removed. After removing excess adipose and con-
nective tissue from the heart, it was drained of blood
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and weighed. The ratios of the total heart weight to
body weight were calculated. The isolated heart was
washed in cold (0–4 C) SNTE buﬀer (0.20 M
sucrose, 0.13 NaCl, l mM Tris–HCl, pH 7.4 [5],
and l mM EGTA neutralized with Tris to pH 7.4),
and the entire left ventricle (LV) was excised from
the heart. TheLVwas separated into four parts, and
stored at )70 C for further analysis.
Preparation of heart mitochondria
One part of LV was minced with scissors, added
with SNTE buﬀer (l.5 ml per g tissue) and homog-
enized at ice temperature with a Model PT l0/35
Polytron homogenizer for 2 cycles of l0 s each.
The homogenate was centrifuged at 500 · g for
l0 min in a Beckman J20.l centrifuge. Then, the
pellet was discarded, and the supernatant was
further centrifuged at 8000 · g for l5 min. The
mitochondrial pellet was resuspended with SNTE
buﬀer. The mitochondrial protein was measured
[16], and prepared for COX enzyme activity assay.
Cytochrome c oxidase activity
Cytochrome c (horse heart, Sigma Chemical Co.
no. C-7752, Type III, prepared without using
TCA) was reduced with dithionite as described [17]
in 50 mM phosphate (K2HPO4–KH2PO4) buﬀer
at pH 7.0 [18]. Reduced cytochrome c was made
fresh for each experiment and stored in an air-tight
container on ice for the assays. COX activity was
measured spectrophotometrically by following the
oxidation of reduced cytochrome c at 550 nm [18]
in 50 mM phosphate buﬀer (pH 7.0) containing
0.5% Tween 80 [19]. Rates are expressed as lmol
cytochrome c oxidized per min per mg mitochon-
drial protein.
Protein extraction and Western blot analysis
The second part of LV was minced with scissors,
homogenized with lysis buﬀer (50 mM Tris
(pH 7.5), 0.5 M NaCl, 1.0 mM EDTA (pH 7.5),
10% glycerol, 1 mM BME, 1% IGEPAL-630 and
proteinase inhibitor cocktail tablet (Roche)) and
spun down 12,000 rpm for 30 min. Then, the
supernatant was collected and stored at )70 C
for further Western blotting. Proteins from animal
heart extracts were quantitated by the Bradford
protein assay [16] and then separated in 10%
gradient sodiumdodecyl sulfate-polyacrylamide
gel electrophoresis. The samples were electropho-
resed at 140 V for 3.5 h and equilibrated for 15 min
in 25 mM Tris–HCl, pH 8.3, containing 192 mM
glycine and 20% (v/v) methanol. Electrophoresed
proteins were transferred to nitrocellulose paper
(Amersham, Hybond-C Extra Supported, 0.45
Micro) at 100 mA for 14 h. Nitrocellulose papers
were incubated at room temperature for 2 h in
blocking buﬀer containing 100 mM Tris–HCl,
pH7.5, 0.9% (w/v) NaCl, 0.1% (v/v) fetal bovine
serum. Antibody of COX-Vb (Santa Cruz Biotech-
nology) was diluted in antibody binding buﬀer
containing 100 mM Tris–HCl, pH7.5, 0.9%(w/v)
NaCl, 0.1% (v/v) Tween 20 and 1%(v/v) fetal
bovine serum. Incubations were performed at room
temperature for 3.5 h. The immunoblot was
washed three times in 50 ml blotting buﬀer for
10 min and then immersed in the second antibody
solution containing alkaline phosphatase goat anti-
rabbit IgG (Promega) for 1 h and diluted 1000-fold
in binding buﬀer. The ﬁlters were then washed in
blotting buﬀer for 10 min three times. Color
development was presented in a 20 ml mixture
consisting of 7 mg nitro blue tetrazolium, 5 mg
5-bromo-4-chloro-3-indolyl-phosphate, 100 mM
NaCl and 5 mM MgCl2 in 100 mM Tris–HCl,
pH 9.5. The immunoblot with antibody against
a-tubulin which was performed with the same
procedure was used as an internal control.
RNA extraction
The third part of LV was used to extract total
RNA using the Ultraspec RNA Isolation System
(Biotecx Laboratories, lnc.) according to direc-
tions supplied by the manufacturer. Each heart
was thoroughly homogenized (1 ml Ultraspec
reagent per 100 mg tissue) with a Polytron homog-
enizer. The RNA precipitate was washed twice by
gentle vortexing with 70% ethanol, collected by
centrifugation at l2,000 · g, dried under vacuum
for 5–l0 min, dissolved in 50–100 ll of diethyl-
pyrocarbonate-treated water, and incubated for
l0-l5 min at 55–60 C.
Measurement of heart mRNA levels by dot blotting
RNA dot blotting was used for the hybridiza-
tion and detection of mRNAs according to the
method described in our previous study [20]. The
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corresponding digoxigenin (DIG)-labeled anti-
sense RNA probes were prepared from pGEM-
7Zf(+) containing a 500-bp cDNA encoding COX
subunit Vb insert (supplied by Dr. Dennis E.
Buetow, Univ. of Illinois, IL, USA, and originally
form Dr. Avadhani, Univ. of Pennsylvania, PA,
USA).
In-situ hybridization of COX-Vb mRNA
and quantitation
The fourth part of LV was used to detect the
COX-Vb mRNA in tissues, using DIG-labeled
antisense RNA probes described above. The pro-
cedures of in-situ hybridization used in this study
were described previously [13].
Statistical analysis
Statistical diﬀerences were analyzed by one-way
analysis of variance (ANOVA). Fisher’s Least
Signiﬁcant Diﬀerence test was used to determine
diﬀerences. p<0.05 was considered statistically
signiﬁcant. Data are expressed as the mean±
standard error (SE).
Results
Hypertensive cardiac hypertrophy in pressure-
overloaded rats
Blood pressure measurements of rats subjected to
complete coarctation clearly demonstrated the
hypertensive eﬀects of the aortic coarctation (Fig-
ure 1). On day 1, 7 and 20 postsurgery, the arterial
systolic blood pressure of sham animals was
137±5, 148±3 and 152±6 mm Hg, respectively,
while that of the coarcted animals was 172±6,
220±10 and 200±10 mm Hg, respectively. Simi-
larly, the arterial diastolic blood pressure of sham
animals was 100±5, 110±5 and 115±5 mm Hg,
while that of the coarcted animals was 128±5,
154±6 and 148±9 mm Hg on day 1, 7 and 20
postsurgery, respectively.
The development of cardic hypertrophy after
complete aortic coarctation is illustrated in Table 1.
Heart weights of sham animals remained unchanged
throughout the postsurgery period. In contrast, by
day 2 after coarctation, hearts of coarcted rats were
signiﬁcantly enlarged and remained so through the
rest of the observation period of 20 days. The heart
weight-to-body weight ratios were increased signif-
icantly from day 2 through 20 postsurgery in the
coarcted animals compared to the 0-day controls. In
sham animals, these ratios remained unchanged
compared to the 0-day controls during the same
postsurgery period.
COX-Vb gene expression
COX-Vb gene expression was measured as levels
of COX-Vb mRNA using in-situ hybridization
(Figure 2) and dot blotting (Figure 3) with an
antisense COX-Vb mRNA DIG-labeled probe in
hearts from rats. The level of hybridized COX-Vb
mRNA in heart sections of coarcted animals
signiﬁcantly increased and reached a peak at day
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Figure 1. Arterial systolic and diastolic blood pressures of
sham-operated and coarcted rats following surgery. Zero day
values represent baseline data from animals sacriﬁced on the
day of surgery. Values are mean±SE. Numbers of animals
measured at each data point are given in Table 1. *p<0.001
represents the comparison to zero day sham animals.
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5. Then, the level declined and returned to the
baseline at day 20 postsurgery (Figure 2a and 2c).
In the sham animals, LV COX-Vb mRNA did not
change during the 20-day postsurgery period
(Figure 2c). The representative images of COX-
Vb gene expression in in-situ hybridization at day 7
are shown in Figure 2b. No hybridization was
detectable in control experiments that used a sense
probe or lacked a probe. The dot blotting of
hybridized COX-Vb mRNA is shown in Fig-
ure 3a. Levels of GAPDH mRNA were used as a
loading control. The density of each COX mRNA
dot was measured and divided by the density of
the corresponding GAPDH mRNA dot. Data
were quantiﬁed by densitometry, Figure 3b.
Clearly, the levels of COX-Vb mRNA are signif-
icantly higher in the coarcted animals compared to
the sham animals at each day postsurgery, and
decreased to basal level at day 20 postsurgery.
Changes of COX-Vb protein level and enzyme
activity
The levels of COX activity and subunit Vb protein
were measured by enzyme kinetic assay and
western blotting, respectively. The eﬀects of the
stress of the surgery were apparent in coarcted
animals. A general increase in cardiac COX enzyme
activity in coarcted animals after day 2 postsurgery
was observed (Table 2). In all cases, COX activity
per mg mitochondnal protein of coarcted hearts
was signiﬁcantly higher than that of sham hearts by
day 10 with an exception at day 20 which was
signiﬁcantly lower. Cardiac COX-speciﬁc activity in
coarcted animals was signiﬁcantly diﬀerent from
that of shams. Compared with 0-day protein level,
the COX-Vb protein levels at day 2, 3, 5 and 7 were
signiﬁcantly increased. Conversely, the COX pro-
tein level at day-20 is signiﬁcantly lower than that at
0-day control (Figure 4).
Impairments of cardiac COX-Vb protein in the rat
models of genetic hypertension
Relative to coarctation-induced pressure-over
loaded rats, the cardiac COX-Vb protein level by
Western blotting was examined in naturally hyper-
tensive rats, spontaneously hypertensive rats (SHR)
and stroke prone SHR (SPSHR), using normoten-
sive Wistar rats (WKY) as a control group, and
results were shown in Figure 5. Using b-actin as a
loading control, cardiac COX-Vb protein levels of
both SHR and SPSHR at age of 4-week, 6-week or
12-week-old were apparently lower than that of
WKY. This indicates that the COX-Vb of hearts
was impaired in genetically hypertensive rats.
Discussion
Cardiac hypertrophy resulting from chronic pres-
sure overload was rapidly induced in the present
model system in which complete coarctation of the
rat abdominal aorta was done between the origins
of the renal artery. In this model system, systolic
blood pressure was found to increase signiﬁcantly
one day following surgery. It reached a peak and
remained fairly constantly above 200 mm Hg after
Table 1. Heart weight and heart weight to body weight ratios of sham-operated and coarcted rats.
Day postsurgery H, g H:B, mg:g
Sham Coarcted Sham Coarcted
0 0.96±0.02 (n = 8) – 3.63±0.08 (n = 8) –
1 0.92±0.03 (n = 7) 0.97±0.02 (n = 7) 3.48±0.08 (n = 7) 3.64±0.14 (n = 7)
2 0.94±0.02 (n = 7) 1.07±0.03* (n = 6) 3.53±0.07 (n = 7) 4.31±0.19* (n = 6)
3 0.95±0.03 (n = 7) 1.13±0.03** (n = 6) 3.47±0.07 (n = 7) 4.56±0.13** (n = 6)
5 0.93±0.01 (n = 7) 1.11±0.02** (n = 6) 3.51±0.08 (n = 7) 4.98±0.18** (n = 6)
7 1.00±0.07 (n = 7) 1.12±0.04* (n = 4) 3.44±0.08 (n = 7) 4.63±0.30*** (n = 4)
10 1.04±0.05 (n = 7) 1.16±0.03* (n = 4) 3.42±0.09 (n = 7) 4.83±0.31*** (n = 4)
20 1.10±0.04 (n = 7) 1.20±0.03* (n = 3) 3.40±0.12 (n = 7) 4.99±0.20** (n = 3)
Data are mean±SE. H and H:B are the heart weights (g) and heart weight to body weight ratios (mg:g), respectively, following
surgery; n, number of animals. Zero day values represent baseline data from animals sacriﬁced on the day of surgery. *p<0.05,
**p<0.025, ***p<0.001 compared to the sham animals.
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3 days. Blood pressures of sham controls remained
around 140 mm Hg during the same postsurgical
period. In the coarcted animals, cardiac hypertro-
phy was observed at one and two days after the
surgery. These results support the view that the
model system using complete coarctation in rats
was a more accelerated model of inducing cardiac
hypertrophy than in the other rat models, for
example, those that are partially coarcted [2,12] or
treated with excess thyroid hormone [12]. To
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Figure 2. In-situ hybridization of LV COX-Vb mRNA. (a) Hybridization of antisense COX-Vb mRNA to LVs of sham-operated
and coarcted rats at 0, 1, 2, 3, 5, 7, 10 and 20 days postsurgery. Arrows point to spots of immuno-detected hybridized antisense
COX-Vb mRNA. (b) Hybridization with a digoxigenin (DIG)-labeled antisense COX-Vb mRNA probe in the LVs from sham-
operated and coarcted animals at day 7 postsurgery. Control hybridizations with a sense DIG-labeled COX-Vb mRNA probe and
with no probe are also shown, (essentially no hybridization is detected as expected). (c) Quantitation of in-situ hybridization of
COX-Vb mRNA in the LVs from sham-operated and coarcted rats following surgery. The 0-day value represents baseline data
from animals sacriﬁced on the day of surgery. Hybridized spots were counted in 100 lm2 sections. Values are expressed as
mean±SE (3 animals per value). Data were analyzed by ANOVA and signiﬁcant diﬀerences between coarcted vs. sham animals on
each day postsurgery. **p<0.01.
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maintain normal tissue function in response to
extra workload during cardiac hypertrophy, the
occurrence of cellular enlargement must be syn-
chronized with proportional increases in the com-
ponents of cellular organelles. In order to provide
the energy needed for the hypertrophic growth and
the functional maintenance of the enlarged cardiac
myocytes, increases in the mitochondrial compo-
nents can be expected.
COX is an enzyme containing thirteen diﬀerent
subunits. Among them, the three largest polypep-
tides (I, II and III subunits) are synthesized within
mitochondria under the control of mitochondria
DNA (mtDNA). The other ten smaller subunits
(IV, Va, Vb, VIa, VIb, VIc, VIIa, VIIb, VIIc and
VIII) are encoded by nuclear DNA (nDNA) and
synthesized in cytosol [6].In the present study,
COX-Vb mRNA detected by in-situ hybridization
and dot blotting increased after day 1 following
the surgery, reached a peak at day 5 or 7 and
decreased to baseline by day 20. The results of the
COX protein and activity demonstrated similar
alteration patterns, and the values on the 20th day
even dramatically dropped below the baseline.
Indeed, by 20 days postsurgery, the mortality of
completely coarcted rats at this time point was
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Figure 3. Gene expression for COX-Vb and GAPDH (loading control) mRNA in the hearts of sham-operated and coarcted rats at
day 1, 2, 3, 5, 7, 10 and 20 postsurgery. (a) COX-Vb probe labeled with DIG on UTP was hybridized to 80 ng mRNA from sham
(S) and coarcted (C) animals. COX-Vb and GAPDH mRNA levels were determined from the dot blots by densitometry. No
hybridization occurred with yeast tRNA which was used as a negative control (data not shown). (b) Graph showed the level of
COX-Vb mRNA relative to the GAPDH mRNA level in the hearts of sham and coarcted rats at day 1 day 1, 2, 3, 5, 7, 10 and 20
postsurgery (n = 3 in all cases). The level of COX-Vb mRNA in sham hearts was standardized to 1.0. *p<0.05 and **p<0.01
when compared to the sham rats.
Table 2. COX-Vb enzyme activity in mitochondria of coarc-
ted (CR) and sham (S) rats on day 1 through 20 postsurgery.
Days
postsurgery
Activity
S CR
1 0.31±0.06 (n = 7) 0.43±0.11 (n = 7)
2 0.30±0.05 (n = 7) 0.44±0.06* (n = 6)
3 0.30±0.03 (n = 7) 0.43±0.05* (n = 6)
5 0.33±0.02 (n = 7) 0.47±0.02* (n = 6)
7 0.33±0.05 (n = 7) 0.49±0.04* (n = 4)
10 0.35±0.03 (n = 7) 0.47±0.03* (n = 4)
20 0.36±0.09 (n = 7) 0.24±0.10** (n = 3)
Activity values are lmoles oxidized cytochrome c/min/mg
mitochondrial protein (mean±SE); n, number of animals.
*p<0.05 represents signiﬁcant increase when compared to the
sham animals. **p<0.05 represents signiﬁcant decrease when
compared to the sham animals.
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around 50% (data not shown). Our ﬁndings
indicate that COX may be an essential adaptive
factor of hypertensive cardiac hypertrophy in early
onset and even prolonged pathological conditions.
A review of the relevant literature [2], however,
reveals discrepancies regarding the behavior of the
mitochondrial components during the onset and
progression of cardiac hypertrophy even when
induced by the same stimulus. Some studies of
cardiac hypertrophy induced by partial aortic
coarctation found an increase in mitochondrial
content, i.e., mitochondrial biogenesis, but this
increase has not always been found in other studies
[2]. Similarly, the mitochondrial responses to
renovascular hypertension-induced cardiac hyper-
trophy are also variable. Two reports, however,
indicate changes in COX activity and the levels of
mRNAs encoding COX subunits remain constant
per mg total heart protein during adaptive cardiac
growth induced by partial aortic coarctation
[2,12]. It has been suggested that mitochondrial
biogenesis is balanced with the increase of ven-
tricular weight for 7 days [12] or even up to
28 days [2] following partial aortic coarctation. On
the other hand, in the present accelerated model of
cardiac hypertrophy, COX-speciﬁc activity was
increased by 30–47% during the period of 1–
10 days postsurgery. This result correlates with the
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Figure 4. Activations of mitochondrial COX-Vb in cardiac tissues of rats. (a) Western blotting analysis of COX-Vb proteins in
LVs of sham-operated and coarcted rats at 0, 1, 2, 3, 5, 7, 10 and 20 days postsurgery. The blotting of a-tubulin was used as a
loading control. (b) Signal intensity of western blotting was quantitated using a PhosphoImager. The averaged result ± SD of
three independent experiments is shown. The 0-day value represents baseline data from animals sacriﬁced on the day of surgery.
*Represents a signiﬁcant increase compared with the control group with p<0.05. #Represents a signiﬁcant decrease compared with
the control group with p<0.05.
Figure 5. COX-Vb level in the left ventricle of hypertensive rats at diﬀerent ages as determined by western blotting. Spontaneously
hypertensive rats (SHR) and stroke prone SHR (SPSHR) were sacriﬁced at diﬀerent ages as indicated. Lysates were prepared from
hearts, and equal amounts of protein were separated by SDS/PAGE and immunoblotting with anti-COX-Vb antibody. b-actin was
used as a loading control. WKY, Wistar rats as a normotensive control; Wk, week.
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ultrastructural study of Legato et al. [21] who
showed that during cardiac hypertrophy mito-
chondrial DNA content in cardiac myocytes was
increased and the mitochondria became smaller
and more densely packed with cristae and inner
membrane proteins. Similarly, in our study, since
the COX activity was calculated by per gram
mitochondrial protein, the increased COX activity
more likely resulted from increased COX content
per mitochondrion than from increased number of
mitochondria. The imposition of a more severe
aortic constriction in the present study than in the
other studies, combined with a resulting greater
pressure overload may lead to disproportionate
changes in mitochondrial activity. In addition, an
increased level of mRNA for the nuclear-encoded
subunit Vb of COX was also observed, and this
met the parallel changes of COX activity reaching
a maximum as the heart hypertrophied. We
suggest that the synthesis of COX is regulated at
the level of transcription in the hypertrophied
heart. Similar behavior of other nuclear-encoded
subunits composed of the enzyme must be pre-
dictable [12]. Because there was a rapid increase of
COX protein and mRNA, COX may be consid-
ered an important adaptive factor of hypertrophic
hearts. The drop in cardiac COX by 20 days
postsurgery in treated rats might indicate the
failure of this increase of COX to balance the
cardiac hypertrophy after long term coarctation,
resulting in heart failure. These ﬁndings are also
consistent with Lin’s study [22], which demon-
strated abnormal cardiac mitochondria, reduced
COX enzyme activity and reduced mtDNA level in
pigs with hypertrophic cardiomyopathy.
Cardiac hypertrophy found in SHR and
SPSHR, other models of genetic hypertension,
showed an apparent reduction of COX protein
level even at ages as young as 4 weeks old.
Interestingly, Tokoro et al. demonstrated a de-
creased antioxidant ability due to lower cardiac
superoxide dismuatse (SOD) activity in SPSHR
[23]. In addition, due to the lack of protection by
histone, several mtDNA encoded subunits of COX
genes are particularly susceptible to oxidative
damage, leading to mutation occurrence [24].
Therefore, the electrophoretic band of deleted
mtDNA analyzed by restriction fragment length
polymorphisms (RFLP) was found in myocardi-
ums of SPSHR [23]. These observations provide
an explanation for the reduction of COX protein
levels in SHR and SPSHR. Although Wanagat’s
study [25] demonstrated that the abnormal activity
of COX was age-associated, we observed a reduc-
tion of COX protein occurring at very young age
in genetically hypertensive rats. We believe genetic
defects resulting in COX dysfunction at young age
in SHR and SPSHR cannot be ruled out. The
average life span of hypertensive rats, SHR and
SPSHR, is around 8 months to one and half years,
which is shorter than that of the normal rats that
have an average life span of 2.5 years, and the
cardiac COX protein in SHR and SPSHR was
down-regulated early. Thus, the failure to have an
increase of COX to balance the cardiac hypertro-
phy may result in heart failure and lead to a
shorter life span in these genetic hypertensive rats.
This is similar to the decrease in COX protein
levels seen at 20 days postsurgery of complete-
coarcted rats.
In summary, the rapid cardiac hypertrophy
induced by complete coarctation of the abdominal
aorta in rats is accompanied by a disproportionate
increase in mitochondrial energy-producing activ-
ity, a result shown here for the ﬁrst time. Addi-
tionally, insuﬃcient oxidative capacity contributes
to the cardiac failure frequently observed in
hypertrophic cardiomyopathies induced by a vari-
ety of conditions [19]. In our study, the dysfunc-
tion of cardiac COX in SHR, SPSHR and
completely coarcted rats long term (20 days) after
surgery suggests that COX might be the key factor
for the cardiac oxidative ability during cardiac
hypertrophy. The rapid cardiac hypertrophy that
develops in the present model provides a unique
system to study the molecular basis underlying the
adaptation of the oxidative system in cells in
response to the demands of hypertrophic growth.
Future work will attempt to identify the mecha-
nism of the increment of COX, using the same
complete coarctation model we used in this study.
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